Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 40, 2009, Pages 17158-17162

  Yuanqing, Lu ^a   Sihong, Song ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

DC activation; rAAV vectors

Indexed keywords

GENE PRODUCT; VIRUS VECTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CLINICAL EVALUATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HOST; HOST CELL; HUMORAL IMMUNITY; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; TRANSGENE;

ADOPTIVE TRANSFER; ALPHA 1-ANTITRYPSIN; ANIMALS; CELL LINE; DENDRITIC CELLS; DEPENDOVIRUS; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; HUMANS; IMMUNITY; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; SPECIES SPECIFICITY; T-LYMPHOCYTES; TRANSFECTION; TRANSGENES;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 70350125101     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0909520106     Document Type: Article

References (32)

1. McCarty DM, Monahan PE, Samulski RJ (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8:1248-1254.
2. Wu Z, Asokan A, Samulski RJ (2006) Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Mol Ther 14:316-327. (Pubitemid 44184972)
3. Vandenberghe LH, Wilson JM (2007) AAV as an immunogen. Curr Gene Ther 7:325-333.
4. Herzog RW (2007) Immune responses to AAV capsid: Are mice not humans after all? Mol Ther 15:649-650.
5. Jooss K, Yang Y, Fisher KJ, Wilson JM (1998) Transduction of dendritic cells by DNAviral vectors directs the immune response to transgene products in muscle fibers. J Virol 72:4212-4223. (Pubitemid 28188726)
6. Xin KQ, et al. (2006) Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells. J Virol 80:11899-11910.
7. Veron P, et al. (2007) Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2. J Virol 81:5385-5394. (Pubitemid 46744447)
8. Vandenberghe LH, et al. (2006) Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat Med 12:967-971.
9. Lu Y, et al. (2006) Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector. J Gene Med 8:730-735. (Pubitemid 43919279)
10. Wang Z, et al. (2005) Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23:321-328. (Pubitemid 41094420)
11. Wang L, et al. (2005) Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood 105:3079-3086. (Pubitemid 40504324)
12. McEachern KA, et al. (2006) AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease. J Gene Med 8:719-729.
13. Ishiwata A, et al. (2006) Phenotype correction of hemophilia A mice with adenoassociated virus vectors carrying the B domain-deleted canine factor VIII gene. Thromb Res 118:627-635. (Pubitemid 44414955)
14. Ziegler RJ, et al. (2007) Correction of the biochemical and functional deficits in fabry mice following AAV8-mediated hepatic expression of alpha-galactosidase A. Mol Ther 15:492-500.
15. Barbon CM, et al. (2005) AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of amouse model of Niemann-Pick disease. Mol Ther 12:431-440.
16. Zhang YC, et al. (2004) Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Ther 11:233-240.
17. Song S, et al. (2001) Stable therapeutic serum levels ofhumanalpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther 8:1299-1306. (Pubitemid 32834298)
18. Manno CS, et al. (2003) AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101:2963-2972. (Pubitemid 36857981)
19. Arruda VR, et al. (2004) Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1. Blood 103:85-92.
20. Mingozzi F, et al. (2003) Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest 111:1347-1356. (Pubitemid 36554705)
21. Song S, et al. (2004) Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther 11:181-186. (Pubitemid 38159690)
22. Leijon K, Hammarstrom B, Holmberg D (1994) Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 6:339-345. (Pubitemid 24055112)
23. Jiang H, et al. (2006) Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. Blood 108:3321-3328. (Pubitemid 44776869)
24. Mays LE, et al. (2009) Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins. J Immunol 182:6051-6060.
25. Jiang H, et al. (2006) Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs. Blood 108:107-115. (Pubitemid 43990618)
26. Gao G, et al. (2004) Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood 103:3300-3302. (Pubitemid 38525655)
27. Cao O, et al. (2007) Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood 110:1132-1140. (Pubitemid 47281408)
28. Wu Z, Miller E, Agbandje-McKenna M, Samulski RJ (2006) Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol 80:9093-9103. (Pubitemid 44359983)
29. Videira PA, et al. (2008) Surface alpha2-3- and alpha2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J 25:259-268.
30. Song S, et al. (2004) Ex vivo transduced liver progenitor cells as a platform for gene therapy in mice. Hepatology 40:918-924. (Pubitemid 39288125)
31. Kaufman CL, et al. (1994) Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84:2436-2446.
32. Lu Y, et al. (2006) Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum Gene Ther 17:625-634. (Pubitemid 43967866)